Last update:

HIV & AIDS news

Medications

Gilead licenses HIV-prevention drug to generic drugmakers

US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income countries.

HIV & AIDS

'Undetectable' HIV patients could hold key to treatments

A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease, says a leading genome expert.

HIV & AIDS

S.Africa's HIV research power couple says fight goes on

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.

HIV & AIDS

How HIV/AIDS got its name

The Centers for Disease Control and Prevention first used the term "AIDS" on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis were marked by a great deal ...

HIV & AIDS

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before the risk of contracting this potentially fatal infection dramatically increases in adolescence.

HIV & AIDS

Ugandan women's autonomy key to safer sex, researchers say

Ugandan women's ability to negotiate the conditions and timing of sex, such as refusing sex and asking for condom use with their partners, is key to preventing several reproductive health outcomes, say experts from the Brown ...

HIV & AIDS

Neural networks adapt to the presence of a toxic HIV protein

Nearly half of HIV infected patients suffer from impaired neurocognitive function. The HIV protein transactivator of transcription (Tat) is an important contributor to HIV neuropathogenesis because it is a potent neurotoxin ...

HIV & AIDS

With treatments, AIDS survival rates in Haiti equal to US

One of the first groups of AIDS patients to receive free HIV drugs in a public health setting in the developing world is living as long as those in the United States, according to research conducted by Weill Cornell Medicine ...

HIV & AIDS

Resistance to key HIV drug 'concerningly common'

HIV drug resistance to tenofovir, an antiretroviral drug vital to most modern HIV treatment and prevention strategies, is surprisingly and worryingly common according to a large study led by UCL (University College London) ...

HIV & AIDS

HIV is still growing, even when undetectable in the blood

A team of international scientists led by Northwestern University found that HIV is still replicating in lymphoid tissue, even when it is undetectable in the blood of patients on antiretroviral drugs.

HIV & AIDS

Can we improve acceptance of HIV testing?

How you offer patients an HIV test has a significant impact on the likelihood of them accepting tests, finds a study published by The BMJ today.

HIV & AIDS

Scientists uncover how part of a protein helps primates fight HIV

Scientists have uncovered part of a protein found in humans and other primates that can help us fight off HIV. In a new study published in the journal Heliyon, researchers discover how this structure can stop HIV from working ...

HIV & AIDS

Pre-exposure prophylaxis (PrEP) as safe as aspirin

PrEP, or pre-exposure prophylaxis, is the first medicine that the Food and Drug Administration has approved to be shown effective to prevent infection with HIV. Nearly 50,000 new cases of HIV occur in the United States every ...

HIV & AIDS

Disparity lies at intersection of HIV, Hodgkin lymphoma

A new study finds a significant racial disparity within a doubly troubled population of patients: those with HIV and Hodgkin lymphoma. In such cases, blacks are at significantly higher risk than whites of not receiving treatment ...

HIV & AIDS

More testing, treatment could dramatically cut new HIV cases

(HealthDay)—As many as two-thirds of new HIV infections could be prevented in men having sex with men (MSM) if more men were tested for the virus, more were treated, and more who don't have HIV took medication to prevent ...

HIV & AIDS

Needle exchange leaders cheer relaxed federal funding ban

Advocates are praising Congress' recent softening of a longtime ban on federal dollars going to needle exchanges amid growing intravenous drug abuse that's spreading hepatitis and HIV in many states.

HIV & AIDS

For HIV-infected, number of daily pills decreasing

(HealthDay)—For HIV-infected patients, the number of pills and doses of antiretrovirals has decreased over the past seven years, according to a study published online Dec. 30 in the Journal of Clinical Pharmacy and Therapeutics.

HIV & AIDS

HIV antibody infusion safely suppresses virus in infected people

A single infusion of a powerful antibody called VRC01 can suppress the level of HIV in the blood of infected people who are not taking antiretroviral therapy (ART), scientists at the National Institutes of Health report in ...

HIV & AIDS

Drug firm announces advance in quest for HIV cure

A Norwegian drug firm on Tuesday announced an advance in its quest for an HIV cure with a drug combination which seeks to force the virus out of its hiding place and kill it.

HIV & AIDS

The mechanism of an AIDS vaccine candidate filmed in vivo

Using innovative technology, scientists from the Institut Pasteur and Inserm have filmed in vivo the process by which an AIDS vaccine candidate, developed by the French Vaccine Research Institute and the ANRS, triggers the ...